Lim et al. (2011) interviewed 433 Singaporean female never-smoker lung cancer patients and 1375 hospital controls, and evaluated six polymorphisms in the interleukin 1-b, interleukin 6 (IL6), cyclooxygenase-2, peroxisome proliferator-activated receptor- and interleukin 1- receptor antagonist (IL1RN) genes